Your browser doesn't support javascript.
loading
Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.
Dolina, Joseph S; Lee, Joey; Brightman, Spencer E; McArdle, Sara; Hall, Samantha M; Thota, Rukman R; Zavala, Karla S; Lanka, Manasa; Ramamoorthy Premlal, Ashmitaa Logandha; Greenbaum, Jason A; Cohen, Ezra E W; Peters, Bjoern; Schoenberger, Stephen P.
Afiliación
  • Dolina JS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Lee J; Cancer Immunology Discovery, Pfizer, San Diego, California, USA.
  • Brightman SE; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
  • McArdle S; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Hall SM; Imaging Facility and.
  • Thota RR; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Zavala KS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Lanka M; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Ramamoorthy Premlal AL; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Greenbaum JA; Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Cohen EEW; Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, California, USA.
  • Peters B; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, California, USA.
  • Schoenberger SP; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.
J Clin Invest ; 133(17)2023 09 01.
Article en En | MEDLINE | ID: mdl-37655661
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunación / Inhibidores de Puntos de Control Inmunológico Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunación / Inhibidores de Puntos de Control Inmunológico Idioma: En Revista: J Clin Invest Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos